These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 11127947)
1. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Li C; Newman RA; Wu QP; Ke S; Chen W; Hutto T; Kan Z; Brannan MD; Charnsangavej C; Wallace S Cancer Chemother Pharmacol; 2000; 46(5):416-22. PubMed ID: 11127947 [TBL] [Abstract][Full Text] [Related]
2. Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Li C; Ke S; Wu QP; Tansey W; Hunter N; Buchmiller LM; Milas L; Charnsangavej C; Wallace S Clin Cancer Res; 2000 Jul; 6(7):2829-34. PubMed ID: 10914731 [TBL] [Abstract][Full Text] [Related]
3. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Li C; Yu DF; Newman RA; Cabral F; Stephens LC; Hunter N; Milas L; Wallace S Cancer Res; 1998 Jun; 58(11):2404-9. PubMed ID: 9622081 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226 [TBL] [Abstract][Full Text] [Related]
5. Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells. Oldham EA; Li C; Ke S; Wallace S; Huang P Int J Oncol; 2000 Jan; 16(1):125-32. PubMed ID: 10601557 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate. Li C; Ke S; Wu QP; Tansey W; Hunter N; Buchmiller LM; Milas L; Charnsangavej C; Wallace S Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1119-26. PubMed ID: 11072171 [TBL] [Abstract][Full Text] [Related]
7. Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability. Milas L; Mason KA; Hunter N; Li C; Wallace S Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):707-12. PubMed ID: 12573758 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Schluep T; Cheng J; Khin KT; Davis ME Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526 [TBL] [Abstract][Full Text] [Related]
10. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Shikanov A; Shikanov S; Vaisman B; Golenser J; Domb AJ Int J Pharm; 2008 Jun; 358(1-2):114-20. PubMed ID: 18406086 [TBL] [Abstract][Full Text] [Related]
12. P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing. Gustafson DL; Long ME; Bradshaw EL; Merz AL; Kerzic PJ Cancer Chemother Pharmacol; 2005 Sep; 56(3):248-54. PubMed ID: 15856231 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of radioresponse by polymer-drug conjugates. Ke S; Milas L; Charnsangavej C; Wallace S; Li C J Control Release; 2001 Jul; 74(1-3):237-42. PubMed ID: 11489500 [TBL] [Abstract][Full Text] [Related]
14. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of water soluble poly(L-glutamic acid)-camptothecin conjugate against resistant human lung cancer xenografted in nude mice. Zou Y; Wu QP; Tansey W; Chow D; Hung MC; Charnsangavej C; Wallace S; Li C Int J Oncol; 2001 Feb; 18(2):331-6. PubMed ID: 11172600 [TBL] [Abstract][Full Text] [Related]
16. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice]. Huo MR; Zhou JP; Wei Y; Lü L Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. Multani AS; Li C; Ozen M; Yadav M; Yu DF; Wallace S; Pathak S Anticancer Res; 1997; 17(6D):4269-74. PubMed ID: 9494519 [TBL] [Abstract][Full Text] [Related]
19. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients. Liu J; Kraut E; Bender J; Brooks R; Balcerzak S; Grever M; Stanley H; D'Ambrosio S; Gibson-D'Ambrosio R; Chan KK Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]